Infection rate of spinal cord stimulators after a screening trial period. A 53-month third party follow-up

Neuromodulation

Volumn 14, Issue 2, 2011, Pages 136-141

  Rudiger, Jan ^a   Thomson, Simon ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b BASILDON HOSPITAL   (United Kingdom)

Author keywords

Infection rate; Screening trial period; SCS; Spinal cord stimulation

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFRADINE; CEFUROXIME; ERYTHROMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASEPSIS; DEVICE INFECTION; FEMALE; FOLLOW UP; HUMAN; HYDROCOLLOID DRESSING; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROFESSIONAL COMPETENCE; RETROSPECTIVE STUDY; SCREENING; SINGLE DRUG DOSE; SPINAL CORD STIMULATOR INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHRONIC PAIN; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; EQUIPMENT CONTAMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; SPINAL CORD; SURGICAL WOUND INFECTION;

EID: 79953740684     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2010.00317.x     Document Type: Article

References (27)

1. De Andres J, Quiroz C, Villanueva V et al. Patient satisfaction with spinal cord stimulation for failed back surgery syndrome. Rev Esp Anestesiol Reanim 2007;54:17-22.
2. Kuchta J, Koulonsakis A, Sturm V. Neurosurgical pain therapy with epidural spinal cord stimulation (SCS). Acta Neurochir Suppl 2007;97:65-70.
3. Kumar K, Taylor RS, Jacques L et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain 2007;132:179-188. (Pubitemid 47500132)
4. North R, Shipley J, Prager J et al. Practice parameters for the use of spinal cord stimulation in the treatment of chronic neuropathic pain. Pain Med 2007;S4:200-275.
5. The British Pain Society.Spinal cord stimulation for the management of pain:recommendations for best clinical practice.A consensus document prepared on behalf of the British Pain Society in consultation with the Society of British Neurological Surgeons. ISBN: 0-9546703-7-X. March 2005. http://www. britishpainsociety.org/book-scs-main.pdf
6. National Institute for Health and Clinical Excellence (NICE, London, UK) (Hill R, Garrett Z, Saile E). Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin. NICE technology appraisal guidance 159. October 2008. http://www.nice.org.uk/TA159
7. Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment, planning and present status, a 22-year experience. Neurosurgery 2006;58:481-496.
8. Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain. A 20-year literature review. J Neurosurg 2004;100:254-267. (Pubitemid 38294988)
9. Turner JA, Loeser JD, Deylo RA, Sanders SB. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications. Pain 2004;108:137-147. (Pubitemid 38251683)
10. Oakley JC, Krames ES, Prager JP et al. A new spinal cord stimulation system effectively relieves chronic, intractable pain: a multicentre prospective clinical study. Neuromodulation 2007;10:262-278. (Pubitemid 46985586)
11. Turner J, Hollingworth W, Comstock B, Deyo R. Spinal cord stimulation for failed back surgery syndrome: outcomes in a workers' compensation setting. Pain 2010;148:14-25.
12. Kumar K, Buchser E, Linderoth B, Meglio M, Van Buyten JP. Avoiding complications from spinal cord stimulation: practical recommendations from an international panel of experts. Neuromodulation 2007;10:24-33. (Pubitemid 46089361)
13. Follett KA, Boortz-Marx RL, Drake JM et al. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anaesthesiology 2004;100:1582-1594. (Pubitemid 38679330)
14. Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstractable chronic critical leg ischaemia. Cochrane Database Syst Rev 2005;3:CD004001.
15. Van Buyten J-P. The performance and safety of an implantable spinal cord stimulation system in patients with chronic pain: a 5 year study. Neuromodulation 2003;6:79-87. (Pubitemid 37322430)
16. Quigley DG, Arnold J, Eldridge PR et al. Long-term outcome of spinal cord stimulation and hardware complications. Stereotact Funct Neurosurg 2003;81:50-56. (Pubitemid 38209815)
17. May SM, Banks C, Thomson SJ. A retrospective, long-term, third-party follow-up of patients considered for spinal cord stimulation. Neuromodulation 2002;5:137-144. (Pubitemid 35167838)
18. Henderson JM, Levy RM, Bedder MD et al. NANS training requirements for spinal cord stimulation devices: selection, implantation, and follow-up. Neuromodulation 2009;12:171-174.
19. Bedder MD, Bedder HF. Spinal cord stimulation surgical technique for the nonsurgically trained. Neuromodulation 2009;12 (Suppl. 1):1-19.
20. Torrens K, Stanley PJ, Ragunathan PL, Bush DJ. Risk of infection with electrical spinal-cord stimulation. Lancet 1997;349:729. (Pubitemid 27107764)
21. Thomas S, Fear M, Humphreys J, Disley L, Waring MJ. The effect of dressings on production of exudate from venous leg ulcers.Wounds 1996;8:145-150.
22. Thomas S, Loveless P.A comparative study of the properties of twelve hydrocolloid dressings. World Wide Wounds 1997;July 1997.http://www. worldwidewounds.com/1997/july/Thomas-Hydronet/hydronet.html
23. Thomas S. Hydrocolloids. J Wound Care 1992;1:27-30.
24. Heffernan A, Martin AJ. A comparison of a modified form of Granuflex (Granseflex extra thin) and a conventional dressing in the management of lacerations, abrasions and minor operation wounds in an accident and emergency department. J Accid Emerg Med 1994;11:227-230.
25. Nemeth AJ, Eaglstein WH, Taylor JR, Peerson LJ, Falanga V. Faster healing and less pain in skin biopsy sites treated with an occlusive dressing. Arch Dermatol 1991;127:1679-1683.
26. Kestle J, Drake J, Milner R et al. Long-term follow-up data fromthe shunt design trial. Pediatr Neurosurg 2000;33:230-236. (Pubitemid 32046018)
27. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection. A prospective study of risk factors. J Neurosurg 2001;94:195-201. (Pubitemid 32799678)